The Institute for Clinical and Economic Review (ICER) has named Dr. David Rind as its first chief medical officer.
Rind, 56, will oversee analyses and critical reviews of a range of clinical interventions. He will also guide policy discussions at the Boston-based not-for-profit research institute.
Rind, a primary-care physician, previously worked as an editor of UpToDate, a resource that assists clinicians in decision-making. He trained physician editors in such subject areas as clinical epidemiology, biostatistics and evidence-based medicine.
In September, ICER began releasing reports that compare the clinical effectiveness of drugs, their prices and their potential impact on the economy before the medications are federally approved and enter the market.
